{"id":"NCT01931475","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Duloxetine in Participants With Chronic Pain Due to Osteoarthritis in China","officialTitle":"Effect of Duloxetine 60mg Once Daily in Patients With Chronic Pain Due to Osteoarthritis in China","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-09","primaryCompletion":"2015-03","completion":"2015-06","firstPosted":"2013-08-29","resultsPosted":"2016-05-23","lastUpdate":"2016-05-23"},"enrollment":407,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis"],"interventions":[{"type":"DRUG","name":"Duloxetine","otherNames":["LY248686","Cymbalta"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Duloxetine","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the efficacy and safety of duloxetine once daily compared with placebo on the reduction of pain due to osteoarthritis (OA) in knee or hip in participants in China.","primaryOutcome":{"measure":"Change From Baseline in the Brief Pain Inventory (BPI) 24-hour Average Pain Score","timeFrame":"Baseline, Week 13","effectByArm":[{"arm":"60 mg Duloxetine","deltaMin":-2.23,"sd":0.11},{"arm":"Placebo","deltaMin":-1.73,"sd":0.11}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":23},"locations":{"siteCount":12,"countries":["China"]},"refs":{"pmids":["36269595","31505082","31010413","30962729","28043937"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":199},"commonTop":["Dry mouth","Somnolence","Nausea","Dizziness","Constipation"]}}